angiotensin ii has been researched along with Capillary Rarefaction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bae, ES; Hong, YS; Yim, HE; Yoo, KH | 1 |
| Ashpole, NM; Ballabh, P; Csiszar, A; Gautam, T; Giles, CB; Sonntag, WE; Tarantini, S; Toth, P; Tucsek, Z; Ungvari, Z; Valcarcel-Ares, MN; Wei, JY; Wren, JD | 1 |
2 other study(ies) available for angiotensin ii and Capillary Rarefaction
| Article | Year |
|---|---|
Capillary rarefaction and altered renal development: the imbalance between pro- and anti-angiogenic factors in response to angiotensin II inhibition in the developing rat kidney.
Topics: Angiogenesis Modulating Agents; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Enalapril; Kidney; Microvascular Rarefaction; Rats | 2018 |
Circulating IGF-1 deficiency exacerbates hypertension-induced microvascular rarefaction in the mouse hippocampus and retrosplenial cortex: implications for cerebromicrovascular and brain aging.
Topics: Aging; Alzheimer Disease; Angiotensin II; Animals; Biomarkers; Blood-Brain Barrier; Cognitive Dysfunction; Gene Expression; Hippocampus; Humans; Hypertension; Insulin-Like Growth Factor I; Male; Mice; Mice, Inbred C57BL; Microvascular Rarefaction; Neocortex; RNA, Messenger | 2016 |